NLTX · Categories · 13D

NLTX - SEC Schedule 13D filings

Neoleukin Therapeutics Inc. (NLTX) sec schedule 13d filings - real-time wire coverage filtered to 13D only.

Recent 13D for NLTX

• 902d
  SEC Form SC 13D filed by Neoleukin Therapeutics Inc.

  SC 13D - Neurogene Inc. (0001404644) (Subject)
• 903d
  SEC Form SC 13D/A filed by Neoleukin Therapeutics Inc. (Amendment)

  SC 13D/A - Neurogene Inc. (0001404644) (Subject)
• 974d
  SEC Form SC 13D/A filed by Neoleukin Therapeutics Inc. (Amendment)

  SC 13D/A - Neoleukin Therapeutics, Inc. (0001404644) (Subject)
• 1028d
  SEC Form SC 13D/A filed by Neoleukin Therapeutics Inc. (Amendment)

  SC 13D/A - Neoleukin Therapeutics, Inc. (0001404644) (Subject)
• 1049d
  SEC Form SC 13D filed by Neoleukin Therapeutics Inc.

  SC 13D - Neoleukin Therapeutics, Inc. (0001404644) (Subject)
• 1057d
  SEC Form SC 13D/A filed by Neoleukin Therapeutics Inc. (Amendment)

  SC 13D/A - Neoleukin Therapeutics, Inc. (0001404644) (Subject)

Other NLTX categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13G
• Form 4
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends